ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Autistic Children May Get Anxiety Relief With Beta Blockers

A recent study by researchers at the University of Missouri found a solution of anxiety relief for Autistic children in the form of propranolol and other beta-blockers. The study, led by David Beversdorf, studied the effect of the drug on kids and young adults with autism spectrum disorder. 

People with anxiety disorders experience unnecessary ‘fight or flight’ activation in response to sensitive threats. Individuals who have autism spectrum disorder experience the same issue during various life stages. Scientists suggest that using similar anxiety drugs for both medical conditions may help control excessive sympathetic system activation. 

Behavioral neurologist David Beversdorf proposed the idea and conducted thorough research on the matter. Seventy-four autistic individuals between 7–24 years of age participated in the trial, where they were given either propranolol or a placebo for 12 weeks. The control group noticed marked benefits and showed less anxious behavior. 

Participants expressed relief from the results. One person who was hesitant to go for a driving test said he felt highly confident after week 6 of the trial. According to Beversdorf, the subject not only passed the test but also started driving regularly.  

Propranolol is a beta-adrenergic agent that works by blocking adrenaline, thus lowering heart rate and blood pressure. An independent epidemiologist at Emory University, Lawrence Scahill, supported the notion of using the drug for anxiety. “If you boost the person’s parasympathetic tone, they won’t be so prone to fight or flight.”

The drug was well tolerated by both the treatment and control groups. The expected therapeutic benefits of reduced heart rate and blood pressure were surveyed without any unfavorable outcomes. “However, a similar anxiety threshold for all entering participants may have produced more notable results,” said Scahill. “A specified age range, e.g., adolescents, may also have produced less diluted effects.”

Beversdorf plans to further research on the subject with a larger trial incorporating marked biomarkers of result detection. “The medicine is readily available, making it easy for trial use,” said Beversdorf.  

Suggested Reads: 

https://pressconnect.ai/news/ai-competition-intensify-microsoft-plans-to-relocate-china-based-employees/

https://pressconnect.ai/news/social-media-outlets-spread-rumours-about-kate-middletons-surgery-and-charless-death/

The post Autistic Children May Get Anxiety Relief With Beta Blockers appeared first on Press Connect.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.